Verapamil, an agent known rapidly to block calcium uptake into islets of Langerhans, has been used to study the roles of intra-and extracellular calcium in the two phases of glucoseinduced insulin release. Rates of calcium uptake and insulin release during the first phase were measured simultaneously over 5 min in rat islets after maintenance in tissue culture for 2 days. Rates of 45 Ca ++ efflux and insulin release during the first and second phases were also measured simultaneously under perifusion conditions. For this, islets were loaded with 45 Ca ++ during the entire maintenance period to complete isotopic equilibrium. Under static incubation conditions 5 µM Verapamil had no effect upon Ca ++ uptake or insulin release in the presence of 2.8 mM glucose. By contrast, glucose-stimulated calcium influx was totally abolished without there being any significant effect upon first phase insulin release. Thus first phase insulin release is independent of increased uptake of extracellular calcium. The lack of effect of 5 µM Verapamil blockade on first phase insulin release was confirmed, under perifusion conditions, and was in marked contrast to the observed 55% inhibition of second phase release. 45 Ca ++ efflux was inhibited during both phases of the insulin release response.
A B S T R A C T Verapamil, an agent known rapidly to block calcium uptake into islets of Langerhans, has been used to study the roles of intra-and extracellular calcium in the two phases of glucose-induced insulin release. Rates of calcium uptake and insulin release during the first phase were measured simultaneously over 5 min in rat islets after maintenance in tissue culture for 2 days. Rates of 45Ca++ efflux and insulin release during the first and second phases were also measured simultaneously under perifusion conditions. For this, islets were loaded with 45Ca++ during the entire maintenance period to complete isotopic equilibrium. Under static incubation conditions 5 
AuM
Verapamil had no effect upon Ca++ uptake or insulin release in the presence of 2.8 mM glucose. By contrast, glucose-stimulated calcium influx was totally abolished without there being any significant effect upon first phase insulin release. Thus first phase insulin release is independent of increased uptake of extracellular calcium. The lack of effect of 5 AM Verapamil blockade on first phase insulin release was confirmed, under perifusion conditions, and was in marked contrast to the observed 55% inhibition of second phase release. 45Ca++ efflux was inhibited during both phases of the insulin release response.
The results show that increased calcium uptake in response to glucose is not involved in the mechanism of first phase insulin release but is required for the full development and maintenance ofthe second phase release. It seems possible that intracellular calcium is the major regulatory control for first phase insulin release and that intracellular calcium and increased uptake of extracellular calcium contribute almost equally to the second phase ofglucose-induced release.
INTRODUCTION
The /8-cells of islets of Langerhans secrete insulin in response to a constant glucose stimulus with a characteristic biphasic pattern (1) (2) (3) (4) . This consists of a rapid surge of insulin output which peaks after a few minutes and then declines (first phase release), followed by a sustained period of slowly increasing insulin output (second phase release). Several explanations for this pattern have been proposed and generally these are along four lines: (a) that the insulin-containing granules in the /3-cells are not a homogeneous pool, but heterogeneous either in their sensitivity to the stimulus, or by fortuitous positioning close to the plasma membrane or other structures involved in the release mechanism (5-7); (b) that the /3-cells themselves have different sensitivities (8) or release rates in response to glucose; (c) that the initial rapid release of insulin causes a feedback inhibition of subsequent release (9-10); (d) that the initiation and maintenance of the constant glucose stimulation sets up a chain of events that results in a biphasic change in the concentration of an intracellular mediator of insulin release (11) . Along the lines of this last possibility, it seemed that the pattern of insulin release could be dictated by a biphasic pattern of the cytosolic Ca++ concentration. Calcium is known to be required for insulin release (12, 13) , and calcium alone has been shown to trigger the release process. For example, when the extracellular Ca++ concentrations are raised (14, 15) or when the ionophore A23187 is used to raise intracellular Ca++ concentrations, a prompt and sustained release of. insulin is achieved (16) (17) (18) (19) .
The effects of glucose on calcium handling have been described by several groups. It seems clear that glucose has at least two actions on the movement of calcium into and out of the islet cells. Thus, it has been shown that glucose has a rapid effect to decrease the rate of efflux of 45Ca++ from preloaded isolated islets (20) (21) (22) , an effect that could raise the cytosol Ca++ concentrations. Glucose has also been shown to cause an increase in Ca++ uptake by the islet (23) (24) (25) (26) (27) (28) (29) (30) (31) [6,6' (n)3H]sucrose (4 ,uM) , as a marker of the extracellular space (33, 34) . The tubes were incubated at 37°C without shaking. At the end of 5 min the incubation was stopped and the islets were separated from the incubation buffer by centrifugation for 15 s at 8,000 x g in a Greiner microfuge (type ZF1, Greiner A. G., Lucerne, Switzerland). By this procedure (26, 28, 35, 36) , the islets were separated from the buffer by passage through the phthalate mixture and into the urea layer. Insulin release was assayed on an aliquot of the supematant buffer. The bottoms of the tubes were cut above the urea layer and placed in (28) .
The insulin release, determined on the same islets as the Ca++ uptake, was corrected to indicate the true release over the 5-min incubation period by subtraction of the values measured at zero-time. Immunoreactive insulin (IRI) was measured by the method of Herbert et al. (37) using rat insulin as standard.
Perifusion system and measurement of 45Ca++ efflux.
Islets used for 45Ca++ efflux studies were labeled during the entire maintenance period with 100 ,uCi of 45CaCl2/ml of culture medium. CaCl2 in the culture medium was 1.8 mM and the final specific radioactivity was approximately 54 ,uCi/ ,umol. 40 islets were perifused per chamber as described in detail elsewhere (4, 38) . The volume of the perifusion chamber was 70 pul, and two rotating oxygen distributors also serving as medium reservoirs were connected to each chamber. The dead space of the system was -1.4 ml and the flow rate was 1.4 ml/min. The perifusate consisted of KRB containing 1.0 mM CaCl2, 0.5% dialyzed bovine serum albumin, and 2.8 mM glucose. The islets, after loading, were placed directly in the perifusion chamber without washing. From zero time to 46 min the islets were perifused with KRBbuffer containing 2.8 mM glucose. At 46 min, 1 min after the solution change, the glucose concentration in the chamber increased to 16.7 mM and the stimulation period continued for another 44 min. Verapamil was added during the stimulation period only. No sample collections were made during the first 40 min of the washing and equilibrium period. Fractions were then collected every minute between 41 and 65 min and thereafter every 5th min. An aliquot of the sample was assayed for IRI. To 0.8 ml ofthe samples, 8 (28) . All uptake studies were therefore performed over the first 5 min after addition of the test agents so that with respect to glucose stimulation, it is the period of first phase insulin release that is under examination. The results are shown in Fig. 1 Fig. 3 . a strong glucose stimulus was employed. Table III , and insulin release was measured over the 5-min period after addition ofthe stimulators. Basal insulin release in the presence of 2.8 mM glucose was the same in the presence and absence of Verapamil. Glucose-stimulated insulin release, as expected, was not significantly inhibited by Verapamil. In contrast, insulin release stimulated by 24 mM KC1 was inhibited by 66%. Thus Verapamil is capable of causing a rapid inhibition of stimulated insulin release.
DISCUSSION
Verapamil inhibits calcium uptake in cardiac muscle (39, 40) , uterus (41) , and pituitary cells (42) . It also inhibits 45Ca++ net uptake by isolated islets incubated for 90 min in the presence of the label (43) and is a useful agent for the exploration of the role of calcium in cell function. In the results reported here it is apparent that the glucose-stimulated unidirectional influx of 45Ca++ in isolated islets of Langerhans is rapidly inhibited by Verapamil. Also, Verapamil inhibits glucose-stimulated 45Ca++ efflux from islets preloaded to isotopic equilibrium. This differs from previous observations with Verapamil (43) and D-600 (44) , the methoxy derivative of Verapamil, in that these agents were not found to affect 45Ca++ efflux. However, in the latter studies the imposed experimental conditions differed from the ones reported here as 45Ca++ efflux was examined in Ca++-deprived media containing ethylene glycol-bis(,8-aminoethyl ether)N,N,N',N'-tetraacetate.
Under such conditions the stimulatory effect of glucose upon 45Ca++ efflux is not seen. Although we have no explanation for the inhibition of 45Ca++ efflux by Verapamil, it should be noted that a similar inhibitory effect was observed when D-600 was used to study 45Ca++ efflux from pituitary cells (45) .
When insulin release was measured over the first 5 min after exposure of the islets to high glucose, Verapamil failed to cause significant inhibition of release despite a total blockade of glucose-stimulated calcium uptake. Under perifusion conditions, the lack of effect of Verapamil on first phase insulin release was confirmed and a differential effect on the two phases of release observed. Thus even though Verapamil failed to inhibit the first phase, it caused a marked inhibition of the second. That Verapamil has a rapid onset of action is shown by the fact that 5 ,uM was sufficient to completely prevent glucose-stimulated Ca++ influx over the first 5 min and by rapid inhibition of insulin release due to high K+ concentration. Thus, failure to observe significant inhibition of first phase release in response to glucose cannot be a result of a slow onset of action. Moreover, Verapamil failed to inhibit the insulin release over 5 min evoked by a submaximal glucose concentration (8.3 mM), which stimulates Ca++ uptake to a lesser extent than 16.7 mM glucose. It seems unlikely, therefore, that failure of Verapamil to inhibit first phase insulin release is owing to a saturation of the release mechanism by maximally raised cytosol Ca++, which in turn would not be affected by inhibition of Ca++ uptake. An alternative explanation for the failure of Verapamil to inhibit first phase insulin release is that the stimulated Ca++ uptake is unrelated to insulin release. This alternative appears unlikely, especially in view of the dose-related effect of glucose on initial Ca++ uptake. The major conclusion from these results is that first phase insulin release is independent of glucose-stimulated uptake of extracellular calcium. Assuming that Ca++ is an essential trigger to insulin release, the first phase release must be the result of changes in the handling of intracellular calcium.
Previous studies on the effects of Verapamil and D-600 have shown inhibition of both phases of insulin release (43, 44, 46) but in these studies the (8-cells were exposed to the agents by perifusion for lengthy periods before the glucose stimulus. These conditions allow the possibilities for Verapamil to gain access to intracellular sites of action or for calcium depletion of the islets before the glucose stimulus is applied. Ca++ depletion is suggested by the finding that under basal conditions net uptake of 45Ca++ after 90 min is markedly reduced (43, 44) . Similarly, in studies in which cobalt was used to block calcium uptake and both phases of insulin release were inhibited, lengthy preperifusion was also performed (26) . That Table I , first by some 55% Thus, in the second phase, the handling d phase insulin release was assessed by meas-of intracellular Ca++ and the net uptake of extracellular effluent collected at 47-51 and 52-90 min, Ca++ both contribute to the full display of insulin reie pattern is drawn so that the second phase lease.
tity that starts immediately after exposure to
In this delineation of the roles of intracellular and d can be extrapolated back through the first the 46th min (heavy solid line). Thus area extracellular Ca++ in biphasic insulin release, it is ascontribution to insulin release during the first sumed that glucose has two effects on Ca++ handliing, at is provided by the second phase process. namely, blockade of efflux (20) (21) (22) and stimulation of its the inhibition of insulin release that was influx (23-28 31) . Both these effects could account the first phase period. As the second phase i ( btited by 55% with 5 ,uM Verapamil, then 55% for the raised cytosol Ca++ and net gain of intracelltialso be inhibited. This degree of inhibition lar Ca++ content. Under the conditions imposed for this similar to area B. This interpretation implies study, the inhibition of efflux is obscured by the rapidse insulin release process is totally unaffected ity of onset of increased 45Ca++ efflux (22 cess that may utilize energy directly, as in a calciumli f Verapamil on the two phases of insulin pump (50, 51) or indirectly as in the case of a Na+/Ca++ expressed in a different fashion from exchange process (52) (53) (54) . It follows that significanlt rable I, when all insulin released during inhibition of Ca++ efflux by glucose must be exerte(d s compared in the presence or absence on an energy-dependent step. Removal of Ca++ from ssuming that both phases of insulin re-the cytosol is achieved by the plasma membrane and lependent components and start simul-by the membranes of intracellular organelles which n by extrapolating the second phase to act as Ca++ stores and buffers. Glucose inhibition of glucose stimulus (see Fig. 4 ), the com-outward fluxes could apply equally to these memsecond phase contributing to the first branes. In consequence, glucose would cause a rise calculated. By using the 16.7 mM glu-in cytosol Ca++ that would result in increased 45Ca++ nts of Fig. 2 , for the extrapolation, this efflux. At present it is not possible to define the quaiounts to 23% ofthe first phase. As second titative aspects of the 45Ca++ efflux, nor do we know is inhibited by 55%, then the second the extent to which the 45Ca++ efflux represents Ca++ tion to the inhibition observed during pumping, diffusion, Ca++/Ca++ exchange, or Na+/Ca++ st phase release should be 0.55 x 23%. exchange. It is known that only an insignificantly small N, is essentially the same as that meas-amount of the 45Ca++ is extruded via the granule secred is in accord with the mechanism for tion process per se (22, 28) . Thus, the overall pattern lin release which is totally independent of 45Ca++ efflux could reflect the cytosol Ca++ concention of Ca++ uptake. Thus, the present tration. Bearing in mind that the specific activity of striking difference in the dependency the intracellular 45Ca++ is continually being decreased (Figs. 2 and 3) . Thus, there is a first phase of 45Ca++ efflux, a well-defined nadir, and subsequently a second rising phase of efflux. The lack of persistence of the second phase of 45Ca++ efflux could be the result of the continually diminishing specific activity of the 45Ca++ in the islets. Thus, if the pattern of 45Ca++ efflux reflects the cytosol Ca++ concentration, then the biphasic insulin release is a reflection of a biphasic change in the cytosol Ca++ concentration. The reason for the transient nature of the first phase of insulin release, and presumably of the first peak in cytosol Ca++ concentration, is not known although an overshoot phenomenon would be a likely explanation.
The possibility that the two phases of insulin release could be regulated by separate mechanisms has been implicit in the observation that in "prediabetic" and mildly diabetic people, the sensitivity to glucose is less in the first phase than in the second (55) (56) (57) (58) . Thus Ca++ storage or ability to mobilize Ca++ stores in response to glucose could be involved in the impaired first phase insulin release in the diabetic state.
